Q4 2024 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2025-02-11 · accession 0000945621-25-000153
$290.9M
Reported value
30
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 717081103 | PFE | PFIZER INC | $30.6M | 10.5% | 1,155,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $25.6M | 8.79% | 320,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $20.7M | 7.12% | 366,166 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $18.2M | 6.27% | 197,500 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $17.2M | 5.93% | 76,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $14.5M | 5.00% | 137,714 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $14.3M | 4.91% | 217,348 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $13.6M | 4.69% | 197,400 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $12.0M | 4.12% | 46,000 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $11.3M | 3.88% | 78,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $10.4M | 3.58% | 88,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $10.3M | 3.54% | 170,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $9.7M | 3.35% | 217,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $9.3M | 3.20% | 158,970 | Common | SOLE |
| N72482149 | — | QIAGEN NV | $9.1M | 3.12% | 203,993 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.2M | 2.83% | 235,842 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $7.3M | 2.52% | 99,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $6.4M | 2.19% | 17,279 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $5.5M | 1.90% | 16,829 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $4.6M | 1.59% | 158,650 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $4.6M | 1.57% | 40,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $4.4M | 1.52% | 29,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $3.9M | 1.34% | 50,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $3.6M | 1.22% | 14,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $3.4M | 1.15% | 276,907 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $2.9M | 1.01% | 65,250 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $2.8M | 0.95% | 22,000 | Common | SOLE |
| 875372AB0 | TNDM 1.5 05/01/25 | TANDEM DIABETES CARE INC | $2.4M | 0.82% | 66,023 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $2.3M | 0.79% | 25,712 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.6M | 0.54% | 48,495 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.